News Flash: NIH has decided to start a massive RCT (n=13,500) on repurposed drugs (Cost: $155 million)
https://www.nih.gov/...vid-19-symptoms
Large clinical trial to study repurposed drugs to treat COVID-19 symptoms
Enrollment will require a positive PCR test, with up to a week of mild to moderate symptoms in those over age 30.
Test drugs will be MAILED to the participants once they are accepted.
Looks like yet another trial that will not be initiating therapy until 10-12 days after symptom onset. This will be well past peak viral load, and well into the hyper-immune response (if this is occurring).
Designed to fail, but it will be a good excuse to delay any EUA/FDA approval for existing meds until after the trial is over.
The trial will follow participants for 90 days to evaluate long COVID, so probably will not publish until next Fall.
Until then... No outpatient therapeutics for you!
Absolutely. Another study that seems designed to fail. At this point you have to wonder if they are doing it on purpose.
How about this one: Study finds vitamin D3 fails to help COVID patients recover.
They again waited until they had sick patients needing hospital care and then gave them likely toxic doses of D3 - 200,000 IU
Hmmmm, I wonder why it failed.
Who designs these "studies"?